Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-blind, Parallel-group, Randomized, Placebo-controlled Clinical Trial, to Evaluate the Effects of Two Different Formulations of a Dietary Supplement on the Lipid Profile in Subjects with Mild Hypercholesterolemia

NCT06810466 is registered in ClinicalTrials.gov with IBSA Farmaceutici Italia Srl as lead sponsor.

NCT NCT06810466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06810466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-blind, Parallel-group, Randomized, Placebo-controlled Clinical Trial, to Evaluate the Effects of Two Different Formulations of a Dietary Supplement on the Lipid Profile in Subjects with Mild Hypercholesterolemia
Lead sponsor
IBSA Farmaceutici Italia Srl
Phase
Not applicable
Overall status
Recruiting
Start date
December 17, 2024
Completion date
January 31, 2026
Enrollment
99 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia and hyperlipidemia, supplementation